Investment Management Associates Inc. ADV Has $834,000 Stock Holdings in Cardinal Health, Inc. (NYSE:CAH)

Investment Management Associates Inc. ADV decreased its stake in Cardinal Health, Inc. (NYSE:CAH) by 5.4% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 7,054 shares of the company’s stock after selling 403 shares during the quarter. Cardinal Health accounts for about 0.4% of Investment Management Associates Inc. ADV’s investment portfolio, making the stock its 19th largest holding. Investment Management Associates Inc. ADV’s holdings in Cardinal Health were worth $834,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of the stock. MWA Asset Management boosted its holdings in shares of Cardinal Health by 2.9% in the fourth quarter. MWA Asset Management now owns 3,324 shares of the company’s stock worth $393,000 after buying an additional 95 shares during the period. Huntington National Bank boosted its stake in Cardinal Health by 0.9% in the 3rd quarter. Huntington National Bank now owns 10,792 shares of the company’s stock worth $1,193,000 after purchasing an additional 100 shares during the period. Frazier Financial Advisors LLC boosted its stake in Cardinal Health by 69.8% in the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock worth $28,000 after purchasing an additional 104 shares during the period. Raleigh Capital Management Inc. raised its stake in Cardinal Health by 29.6% during the 4th quarter. Raleigh Capital Management Inc. now owns 464 shares of the company’s stock valued at $55,000 after purchasing an additional 106 shares during the period. Finally, Patron Partners LLC lifted its holdings in shares of Cardinal Health by 6.1% in the fourth quarter. Patron Partners LLC now owns 2,043 shares of the company’s stock valued at $242,000 after purchasing an additional 117 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Up 0.5 %

Shares of NYSE:CAH opened at $127.35 on Friday. The stock has a market capitalization of $30.76 billion, a PE ratio of 23.76, a P/E/G ratio of 1.48 and a beta of 0.63. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $132.84. The firm has a fifty day moving average price of $123.45 and a 200 day moving average price of $116.88.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, sell-side analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a $0.5056 dividend. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.59%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health’s payout ratio is 37.69%.

Analyst Ratings Changes

A number of brokerages have recently weighed in on CAH. Morgan Stanley lifted their price target on Cardinal Health from $136.00 to $142.00 and gave the company an “overweight” rating in a report on Friday, January 31st. StockNews.com cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd. Jefferies Financial Group raised shares of Cardinal Health from a “hold” rating to a “buy” rating and increased their price target for the stock from $140.00 to $150.00 in a research report on Wednesday, February 5th. TD Cowen upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating and raised their price target for the stock from $130.00 to $144.00 in a report on Wednesday, January 8th. Finally, Citigroup upped their price objective on shares of Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research note on Friday, January 10th. Four equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $136.87.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.